Meaghan Dendy
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Oncology 4
- Co-authors
- Ramon Parsons (4 shared papers)Matthias Szabolcs (1 shared paper)Ηλίας Στρατικόπουλος (1 shared paper)Hyun S. Kim (5 shared papers)Ming‐Ming Zhou (1 shared paper)Céline Lefèbvre (1 shared paper)Johannes Ludwig (5 shared papers)Hanina Hibshoosh (3 shared papers)
- Journals
- Oncotarget (2 papers)Liver Cancer (1 paper)Cancer Cell (1 paper)BMC Cancer (1 paper)Surgical Oncology (1 paper)
- Partner nations
- United StatesGermanyFinland
In The Last Decade
Meaghan Dendy
12 papers receiving 600 citations
Peers
Comparison fields: 5 of 66
- Hepatology 93
- Hematology 73
- Molecular Biology 413
- Oncology 128
- Cancer Research 57
Countries citing papers authored by Meaghan Dendy
This map shows the geographic impact of Meaghan Dendy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meaghan Dendy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meaghan Dendy more than expected).
Fields of papers citing papers by Meaghan Dendy
This network shows the impact of papers produced by Meaghan Dendy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meaghan Dendy. The network helps show where Meaghan Dendy may publish in the future.
Co-authors
The 25 scholars most cited alongside Meaghan Dendy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 252 | |
| 2 | 2015 | 191 | |
| 3 | 2017 | 37 | |
| 4 | 2019 | 34 | |
| 5 | 2016 | 26 | |
| 6 | 2017 | 22 | |
| 7 | 2015 | 14 | |
| 8 | 2017 | 10 | |
| 9 | 2018 | 10 | |
| 10 | 2018 | 5 | |
| 11 | 2017 | 3 | |
| 12 | 2013 | 2 |
About Meaghan Dendy
Meaghan Dendy is a scholar working on Hepatology, Oncology, Molecular Biology, Pathology and Forensic Medicine and Dermatology, having authored 12 papers that have together received 606 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Mechanisms and Therapy (2 papers), Cancer and Skin Lesions (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Sympathectomy and Hyperhidrosis Treatments (1 paper), Ubiquitin and proteasome pathways (1 paper), Protein Degradation and Inhibitors (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Hepatology (93 citations), Hematology (73 citations), Molecular Biology (413 citations), Oncology (128 citations) and Cancer Research (57 citations). Meaghan Dendy has collaborated with scholars based in United States, Germany and Finland. Frequent co-authors include Ramon Parsons, Matthias Szabolcs, Ηλίας Στρατικόπουλος, Hyun S. Kim, Ming‐Ming Zhou, Céline Lefèbvre, Johannes Ludwig, Hanina Hibshoosh, Nicole Steinbach and Hannah E. Goldstein. Their work appears in journals such as Oncotarget, Liver Cancer, Cancer Cell, BMC Cancer and Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.